Akeso Biopharma (Cayman) Limited ("Akeso") announced its board of directors and their respective roles and functions on July 1, 2024. The board of directors is chaired by Dr. Xia Yu, executive director, president and chief executive officer, and includes Dr. Li Baiyong, Dr. Wang Zhongmin, Dr. Zhang Peng and others. Non-executive director is Mr. Xie Ronggang, and independent non-executive directors include Dr. Zeng Junwen, Dr. Xu Yan, and Mr. TAN Bo. The company has established three board committees, namely the audit committee, the remuneration committee, and the nomination committee, and clearly stated the positions of each director in these committees, including committee chairman (C) and committee member (M). The composition of the board of directors and the functions of its committees reflect Akeso's transparency and commitment to corporate governance structure.

Akeso Biopharma (Cayman) Limited ("Akeso") announced its board of directors and their respective roles and functions on July 1, 2024. The board of directors is chaired by Dr. Xia Yu, executive director, president and chief executive officer, and includes Dr. Li Baiyong, Dr. Wang Zhongmin, Dr. Zhang Peng and others. Non-executive director is Mr. Xie Ronggang, and independent non-executive directors include Dr. Zeng Junwen, Dr. Xu Yan, and Mr. TAN Bo. The company has established three board committees, namely the audit committee, the remuneration committee, and the nomination committee, and clearly stated the positions of each director in these committees, including committee chairman (C) and committee member (M). The composition of the board of directors and the functions of its committees reflect Akeso's transparency and commitment to corporate governance structure.